Latest

Non-Small Cell Lung Cancer: Nivolumab vs Docetaxel for Long-Term Efficacy

Non-Small Cell Lung Cancer: Nivolumab vs Docetaxel for Long-Term Efficacy

Results of two phase 3 studies found that nivolumab provided superior overall survival vs docetaxel in people with non-small cell lung cancer.

Small Cell Lung Cancer Survival With Anticoagulant Therapy

Small Cell Lung Cancer Survival With Anticoagulant Therapy

Trial results provided strong evidence against the use of anticoagulant low molecular weight heparin in SCLC.

Anti-Inflammatory Therapy With Canakinumab May Reduce Lung Cancer Rates

Anti-Inflammatory Therapy With Canakinumab May Reduce Lung Cancer Rates

Patients with lung cancer and atherosclerosis diagnosis may benefit from anti-inflammatory therapy with canakinumab.

Quality of Life Benefits of Yoga in Non-Small Cell Lung Cancer

Quality of Life Benefits of Yoga in Non-Small Cell Lung Cancer

Patients with NSCLC experienced improvements in both function and quality of life with yoga therapy.

Potential Delays in Non-Small Cell Lung Cancer Therapy

Potential Delays in Non-Small Cell Lung Cancer Therapy

Study results stress the importance of a multiethnic support system for patients needing to overcome communication barriers.

New "Pan-Can" Model More Accurately Predicts Lung Cancer Risk

New "Pan-Can" Model More Accurately Predicts Lung Cancer Risk

PanCan study effectively identified patients who eventually developed early-stage lung cancer, compared to other predictive models.

Updated Lung Cancer Screening Guidelines Released at CHEST

Updated Lung Cancer Screening Guidelines Released at CHEST

The ACCP just released new lung cancer screening guidelines.

Lung Cancer Screening Endorsed by Pulmonary and Primary Care Providers

Lung Cancer Screening Endorsed by Pulmonary and Primary Care Providers

Researchers surveyed knowledge, beliefs, attitudes, barriers, and facilitators related to screening patients for lung cancer.

Small-cell Lung Cancer Benefits From Maintenance Therapy With Pazopanib

Small-cell Lung Cancer Benefits From Maintenance Therapy With Pazopanib

Pazopanib improves progression-free survival in patients with small-cell lung cancer.

Gefitinib Treatment Should Be Avoided Prior to Chemotherapy in Non-small Cell Lung Cancer

Gefitinib Treatment Should Be Avoided Prior to Chemotherapy in Non-small Cell Lung Cancer

First generation EGFR tyrosine kinase inhibitors should be used in combination with chemotherapy if a patient has progressive EGFR mutation-positive non-small cell lung cancer.

Dacomitinib vs Gefitinib for Progression-Free Survival in Non-small Cell Lung Cancer

Dacomitinib vs Gefitinib for Progression-Free Survival in Non-small Cell Lung Cancer

Dacomitinib improved progression-free survival in patients with non-small cell lung cancer.

Case Report: Small Cell Lung Cancer Case With Tumor Lysis Syndrome

Case Report: Small Cell Lung Cancer Case With Tumor Lysis Syndrome

Tumor lysis syndrome can occur even in the absence of chemotherapy, and clinicians should remain suspicious when patients demonstrate laboratory abnormalities.

Greater Depth of Response to Therapy Improves Survival in Non-small Cell Lung Cancer

Greater Depth of Response to Therapy Improves Survival in Non-small Cell Lung Cancer

Overall and progression-free survival were improved with greater depth of response to therapy in non-small cell lung cancer.

Thoracic Radiotherapy Does Not Increase Risk for Immune-Related AEs in Lung Cancer

Thoracic Radiotherapy Does Not Increase Risk for Immune-Related AEs in Lung Cancer

Patients with metastatic lung cancer who receive both both immune checkpoint inhibitors and thoracic radiotherapy.do not have a greater risk for immune-related adverse events.

Non-small Cell Lung Cancer Survival Improved With Adoptive Cellular Immunotherapy

Non-small Cell Lung Cancer Survival Improved With Adoptive Cellular Immunotherapy

Adjuvant adoptive cellular immunotherapy plus chemotherapy improved survival in patients with resected non-small cell lung caner.

Non-small Cell Lung Cancer Staging Accuracy Tied to Nodal Examination

Non-small Cell Lung Cancer Staging Accuracy Tied to Nodal Examination

Thoroughness of nodal examination determines prognostic value of non-small cell lung cancer staging.

Non-small Cell Lung Cancer Metastasis at Diagnosis May Be Predicted by Genetic Mutations

Non-small Cell Lung Cancer Metastasis at Diagnosis May Be Predicted by Genetic Mutations

ROS1 and ALK rearrangements in patients with non-small cell lung cancer may predict different metastasis distributions at diagnosis.

Diagnostic Test Can Identify Biomarkers to Detect Lung Cancer

Diagnostic Test Can Identify Biomarkers to Detect Lung Cancer

A new diagnostic test and algorithm may be able to diagnose lung cancer from tumor-educated platelets.

Lung Cancer Is a Significant Cause of Death in Smokers Living With HIV

Lung Cancer Is a Significant Cause of Death in Smokers Living With HIV

Smokers with HIV who are adherent to antiretroviral therapy are still likely to die from lung cancer.

Standard vs High-Dose Chemoradiation in Stage 3 Non-small Cell Lung Cancer

Standard vs High-Dose Chemoradiation in Stage 3 Non-small Cell Lung Cancer

Higher doses of chemoradiation in stage 3 non-small cell lung cancer did not improve overall survival rates.

Sign Up for Free e-newsletters